Home›Stock Screener›Cell Point›Financial Statements

Cell Point Complete Financial Statements

6 Years of Data
2025 - 2020

In FYNone, Cell Point (CELLPOINT) reported revenue ₹148 Cr, net profit ₹3 Cr and EPS ₹2.10, with a net profit margin of 0.6% and ROE of 2.7%. Full financial statements from FY2020 to FY2025 (6 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Check Cell Point market cap to track the company's total market size over time.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 0.61% 2025 data
EBITDA Margin 2.76% 2025 data
Operating Margin 2.00% 2025 data
Return on Assets 1.45% 2025 data
Return on Equity 2.70% 2025 data

Balance Sheet Ratios

Current Ratio 39.50 2025 data
Equity Ratio 53.62% 2025 data
Asset Turnover 2.36 2025 data

CELLPOINT Revenue, Net Profit & EBITDA — Year-on-Year Growth

CELLPOINT YoY (March 2025 vs Period) — revenue -54.6%, net profit +50.0%, EBITDA +11.1%, expenses -56.5%. For live price, earnings ratios and company overview, see CELLPOINT screener.

Revenue Growth
-54.6%
Year-over-Year
Net Profit Growth
+50.0%
Year-over-Year
EBITDA Growth
+11.1%
Year-over-Year
Expense Growth
-56.5%
Year-over-Year
Assets Growth
+3.0%
Year-over-Year
Equity Growth
+2.8%
Year-over-Year
Operating Cash Flow Growth
+85.7%
Year-over-Year
Investing Cash Flow Growth
+106.5%
Year-over-Year
Financing Cash Flow Growth
-117.9%
Year-over-Year

CELLPOINT Income Statement — Revenue, EBITDA & Net Profit

Cell Point revenue ₹148 Cr, EBITDA ₹10 Cr, net profit ₹3 Cr, EPS ₹2.10 (None) — net profit margin 0.6%. See CELLPOINT P/B ratio to compare market price against book value per share.

Periods ₹ Crores
Particulars None March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Revenue 148 326 323 297 270 224 278
Expenses 138 317 313 278 259 215 268
EBITDA 10 9 10 19 12 8 10
Operating Profit Margin % 3.00% 2.00% 3.00% 6.00% 4.00% 3.00% 3.00%
Depreciation 1 3 2 1 1 1 2
Interest 5 5 6 9 8 6 6
Profit Before Tax 5 3 3 10 2 1 2
Tax 1 1 1 3 1 1 1
Net Profit 3 2 2 7 2 1 2
Earnings Per Share (₹) 2.10 1.21 0.97 4.93 1.21 6.08 14.06

CELLPOINT Balance Sheet — Assets, Liabilities & Shareholders' Equity

CELLPOINT total assets ₹138 Cr, total equity ₹74 Cr, total liabilities ₹ Cr (2025) — ROE 2.7%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021 2020
ASSETS
Total Assets 138 134 95 83 65 56
Current Assets 79 71 60 50 32 31
Fixed Assets 37 33 18 19 19 19
Capital Work in Progress 1 0 0 0 0 0
Investments 0 0 0 0 0 0
Other Assets 101 101 76 64 46 37
LIABILITIES
Total Liabilities
Current Liabilities 2 2 19 20 24 22
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 74 72 20 13 12 11
Share Capital 19 19 14 1 1 1
Reserves & Surplus 56 53 6 12 11 10

CELLPOINT Cash Flow Statement — Operating, Investing & Financing

Cell Point operating cash flow ₹-1 Cr, investing ₹2 Cr, financing ₹-7 Cr, net cash flow ₹-6 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities -1 -7 6 0 2 2
Investing Activities 2 -31 -3 -1 -1 -1
Financing Activities -7 39 -1 6 0 1
Net Cash Flow -6 2 2 5 1 1